Children of more empowered women are less likely to be left without vaccination in low- and middle-income countries: A global analysis of 50 DHS surveys.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
2022
Historique:
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 2 4 2022
Statut: epublish

Résumé

To help provide a global understanding of the role of gender-related barriers to vaccination, we have used a broad measure of women's empowerment and explored its association with the prevalence of zero-dose children aged 12-23 months across many low- and middle-income countries, using data from standardized national household surveys. We used data from Demographic and Health Surveys (DHS) of 50 countries with information on both women's empowerment and child immunisation. Zero-dose was operationally defined as the proportion of children who failed to receive any doses of the diphtheria, pertussis, and tetanus containing vaccines (DPT). We measured women's empowerment using the SWPER Global, an individual-level indicator estimated for women aged 15-49 years who are married or in union and with three domains: social independence, decision-making and attitude towards violence. We estimated two summary measures of inequality, the slope index of inequality (SII) and the concentration index (CIX). Results were presented for individual and pooled countries. In the country-level (ecological) analyses we found that the higher the proportion of women with high empowerment, the lower the zero-dose prevalence. In the individual level analyses, overall, children with highly-empowered mothers presented lower prevalence of zero-dose than those with less-empowered mothers. The social independence domain presented more consistent associations with zero-dose. In 42 countries, the lowest zero-dose prevalence was found in the high empowerment groups, with the slope index of inequality showing significant results in 28 countries. When we pooled all countries using a multilevel Poisson model, children from mothers in the low and medium levels of the social independence domain had respectively 3.3 (95% confidence interval (CI) = 2.3, 4.7) and 1.8 (95% CI = 1.5, 2.1) times higher prevalence of zero-dose compared to those in the high level. Our country-level and individual-level analyses support the importance of women's empowerment for child vaccination, especially in countries with weaker routine immunisation programs.

Sections du résumé

Background UNASSIGNED
To help provide a global understanding of the role of gender-related barriers to vaccination, we have used a broad measure of women's empowerment and explored its association with the prevalence of zero-dose children aged 12-23 months across many low- and middle-income countries, using data from standardized national household surveys.
Methods UNASSIGNED
We used data from Demographic and Health Surveys (DHS) of 50 countries with information on both women's empowerment and child immunisation. Zero-dose was operationally defined as the proportion of children who failed to receive any doses of the diphtheria, pertussis, and tetanus containing vaccines (DPT). We measured women's empowerment using the SWPER Global, an individual-level indicator estimated for women aged 15-49 years who are married or in union and with three domains: social independence, decision-making and attitude towards violence. We estimated two summary measures of inequality, the slope index of inequality (SII) and the concentration index (CIX). Results were presented for individual and pooled countries.
Results UNASSIGNED
In the country-level (ecological) analyses we found that the higher the proportion of women with high empowerment, the lower the zero-dose prevalence. In the individual level analyses, overall, children with highly-empowered mothers presented lower prevalence of zero-dose than those with less-empowered mothers. The social independence domain presented more consistent associations with zero-dose. In 42 countries, the lowest zero-dose prevalence was found in the high empowerment groups, with the slope index of inequality showing significant results in 28 countries. When we pooled all countries using a multilevel Poisson model, children from mothers in the low and medium levels of the social independence domain had respectively 3.3 (95% confidence interval (CI) = 2.3, 4.7) and 1.8 (95% CI = 1.5, 2.1) times higher prevalence of zero-dose compared to those in the high level.
Conclusions UNASSIGNED
Our country-level and individual-level analyses support the importance of women's empowerment for child vaccination, especially in countries with weaker routine immunisation programs.

Identifiants

pubmed: 35356658
doi: 10.7189/jogh.12.04022
pii: jogh-12-04022
pmc: PMC8943525
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04022

Informations de copyright

Copyright © 2022 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests: The authors completed the ICMJE Unified Competing Interest Form (available upon request from the corresponding author), and declare no conflicts of interest.

Références

Soc Sci Med. 2016 Nov;169:119-131
pubmed: 27716549
Matern Child Health J. 2021 Jan;25(1):95-106
pubmed: 33226578
EClinicalMedicine. 2021 Nov 06;42:101196
pubmed: 34805814
J Glob Health. 2020 Dec;10(2):020406
pubmed: 33214898
J Public Health (Oxf). 2021 May 31;:
pubmed: 34059913
Br Med Bull. 2015 Mar;113(1):5-14
pubmed: 25649959
Vaccine. 2021 Jul 22;39(32):4564-4570
pubmed: 33744046
Asia Pac J Public Health. 2014 Jul;26(4):401-13
pubmed: 22652247
Demography. 2001 Feb;38(1):115-32
pubmed: 11227840
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Indian Pediatr. 2012 Mar;49(3):203-23
pubmed: 22484740
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S87-S97
pubmed: 33189504
Lancet Glob Health. 2020 Dec;8(12):e1473-e1488
pubmed: 33091371
PLoS Med. 2013;10(5):e1001390
pubmed: 23667332
Paediatr Perinat Epidemiol. 2021 Sep;35(5):549-556
pubmed: 34080692
Health Care Women Int. 2015;36(1):57-69
pubmed: 24028632
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34969682
J Glob Health. 2020 Dec;10(2):020343
pubmed: 33274055
J Glob Health. 2021 Mar 01;11:04015
pubmed: 33791094
Vaccines (Basel). 2021 Jun 13;9(6):
pubmed: 34199179
Glob Public Health. 2015 Oct;10(9):1078-91
pubmed: 25635475
Health Care Women Int. 2010 Jul;31(7):599-620
pubmed: 20526926
Lancet Glob Health. 2021 Dec;9(12):e1697-e1706
pubmed: 34798029
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S24-S33
pubmed: 33131990
Lancet Glob Health. 2017 Sep;5(9):e916-e923
pubmed: 28755895
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
BMC Infect Dis. 2017 Dec 28;17(1):801
pubmed: 29281990
Vaccine. 2020 Jul 14;38(33):5379-5383
pubmed: 32430149
BMJ Open. 2017 Mar 10;7(3):e013853
pubmed: 28283489

Auteurs

Andrea Wendt (A)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Thiago M Santos (TM)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Bianca O Cata-Preta (BO)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Janaína C Costa (JC)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Tewodaj Mengistu (T)

Gavi, the Vaccine Alliance, Geneva, Switzerland.

Daniel R Hogan (DR)

Gavi, the Vaccine Alliance, Geneva, Switzerland.

Cesar G Victora (CG)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Aluísio J D Barros (AJD)

International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH